Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scar Remodeling after Burn Injury using Adipose-derived Allogeneic Stem Cells (ScarASC)
2024-519160-41-00Phase 2Authorised
- Sponsor
- Rigshospitalet
- Start
- Apr 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of culture-expanded adipose-derived regenerative cells in Hypertrophic Scar (HS) (2 arms), sponsored by Rigshospitalet. Primary endpoint: Change in total patient score of the Danish Patient and Observer Scar Assessment Scale version 3.0. Planned start Apr 2025; status: authorised.
02
Drugs
culture-expanded adipose-derived regenerative cells
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on 2024-519160-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519160-41-00.